AL
TEVA icon

Airain Ltd’s Teva Pharmaceuticals TEVA Stock Holding History

Airain Ltd’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$10.3M Sell
310,487
-346,407
-53% -$10.7M 0.46% 55
2017
Q1 		$21.1M Buy
656,894
+124,232
+23% +$4.24M 1.03% 7
2016
Q4 		$19.3M Buy
532,662
+36,808
+7% +$1.47M 1.56% 7
2016
Q3 		$22.8M Buy
495,854
+352,249
+245% +$18.4M 1.35% 2
2016
Q2 		$7.21M Sell
143,605
-192,104
-57% -$10.2M 0.42% 67
2016
Q1 		$18M Buy
335,709
+242,498
+260% +$14.2M 1.24% 7
2015
Q4 		$6.12M Sell
93,211
-225,948
-71% -$14M 0.42% 60
2015
Q3 		$18M Buy
319,159
+120,234
+60% +$7.8M 1.08% 3
2015
Q2 		$11.8M Buy
198,925
+61,363
+45% +$3.79M 0.66% 21
2015
Q1 		$8.57M Buy
137,562
+74,855
+119% +$4.35M 0.52% 50
2014
Q4 		$3.61M Sell
62,707
-47,121
-43% -$2.63M 0.3% 90
2014
Q3 		$5.9M Buy
109,828
+2,105
+2% +$112K 0.4% 62
2014
Q2 		$5.65M Buy
107,723
+102,411
+1,928% +$5.23M 0.46% 51
2014
Q1 		$281K Sell
5,312
-31,616
-86% -$1.46M 0.05% 503
2013
Q4 		$1.48M Buy
+36,928
New +$1.45M 0.19% 136

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Airain Ltd's TEVA Position: Q2 2017 in Review

Airain Ltd reduced its Teva Pharmaceuticals (TEVA) stake by 53% in Q2 2017, selling an estimated $10.7M and leaving 310,487 shares worth $10.3M. The position accounts for 0.46% of the portfolio, ranked #55.

Airain Ltd first reported a position in TEVA in Q4 2013 and has held it in 15 quarters since. The position peaked at $22.8M in Q3 2016. 648 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Airain Ltd held 310,487 shares of Teva Pharmaceuticals worth $10.3M as of Q2 2017.
  • Airain Ltd sold 346,407 Teva Pharmaceuticals shares in Q2 2017, an estimated $10.7M.
  • Teva Pharmaceuticals made up 0.46% of Airain Ltd's portfolio in Q2 2017, its #55 holding.
  • Airain Ltd first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 15 quarters since.
  • Airain Ltd's Teva Pharmaceuticals position peaked at $22.8M in Q3 2016.
  • 648 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.